AMZN Amazon.com | $234.09
-0.4% | 1/22/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $270.00 -> $270.00 | Low | View details for Cantor Fitzgerald rating of Amazon.com (NASDAQ:AMZN) on 1/22/2025 |
STX Seagate Technology | $107.20
-0.9% | 1/22/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Neutral | $120.00 -> $120.00 | High | View details for Cantor Fitzgerald rating of Seagate Technology (NASDAQ:STX) on 1/22/2025 |
RARE Ultragenyx Pharmaceutical | $43.10
+0.4% | 1/22/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $118.00 -> $118.00 | Medium | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 1/22/2025 |
SMTI Sanara MedTech | $37.93
+0.5% | 1/22/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $44.00 -> $44.00 | High | View details for Cantor Fitzgerald rating of Sanara MedTech (NASDAQ:SMTI) on 1/22/2025 |
META Meta Platforms | $626.06
+0.4% | 1/22/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $730.00 -> $720.00 | Low | View details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 1/22/2025 |
GOOGL Alphabet | $198.59
+0.1% | 1/22/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $215.00 -> $210.00 | Medium | View details for Cantor Fitzgerald rating of Alphabet (NASDAQ:GOOGL) on 1/22/2025 |
KROS Keros Therapeutics | $11.44
+0.4% | 1/21/2025 | Downgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Neutral | | Medium | View details for Cantor Fitzgerald rating of Keros Therapeutics (NASDAQ:KROS) on 1/21/2025 |
AMPX Amprius Technologies | $3.51
+1.6% | 1/21/2025 | Initiated by | Cantor Fitzgerald | Analyst Derek Soderberg | Overweight | $10.00 | High | View details for Cantor Fitzgerald rating of Amprius Technologies (NYSE:AMPX) on 1/21/2025 |
ZM Zoom Video Communications | $77.21
-2.6% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $87.00 | N/A | View details for Cantor Fitzgerald rating of Zoom Video Communications (NASDAQ:ZM) on 1/16/2025 |
TEAM Atlassian | $264.02
+1.2% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $264.00 | N/A | View details for Cantor Fitzgerald rating of Atlassian (NASDAQ:TEAM) on 1/16/2025 |
|
SNOW Snowflake | $176.04
-0.8% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Strong-Buy | $201.00 | N/A | View details for Cantor Fitzgerald rating of Snowflake (NYSE:SNOW) on 1/16/2025 |
PLTR Palantir Technologies | $77.64
+1.0% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $72.00 | N/A | View details for Cantor Fitzgerald rating of Palantir Technologies (NASDAQ:PLTR) on 1/16/2025 |
ORCL Oracle | $184.79
+0.3% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Strong-Buy | $214.00 | N/A | View details for Cantor Fitzgerald rating of Oracle (NYSE:ORCL) on 1/16/2025 |
NOW ServiceNow | $1,121.23
-0.4% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Strong-Buy | $1,332.00 | N/A | View details for Cantor Fitzgerald rating of ServiceNow (NYSE:NOW) on 1/16/2025 |
NICE NICE | $159.44
-3.4% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $176.00 | N/A | View details for Cantor Fitzgerald rating of NICE (NASDAQ:NICE) on 1/16/2025 |
MSFT Microsoft | $442.93
-0.7% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Strong-Buy | $509.00 | N/A | View details for Cantor Fitzgerald rating of Microsoft (NASDAQ:MSFT) on 1/16/2025 |
MNDY monday.com | $245.21
-3.4% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Strong-Buy | $292.00 | N/A | View details for Cantor Fitzgerald rating of monday.com (NASDAQ:MNDY) on 1/16/2025 |
MDB MongoDB | $255.02
-2.2% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Strong-Buy | $344.00 | N/A | View details for Cantor Fitzgerald rating of MongoDB (NASDAQ:MDB) on 1/16/2025 |
INFA Informatica | $24.61
-1.3% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $29.00 | N/A | View details for Cantor Fitzgerald rating of Informatica (NYSE:INFA) on 1/16/2025 |
ESTC Elastic | $104.87
+3.6% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $108.00 | N/A | View details for Cantor Fitzgerald rating of Elastic (NYSE:ESTC) on 1/16/2025 |
DT Dynatrace | $54.93
+1.0% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $58.00 | N/A | View details for Cantor Fitzgerald rating of Dynatrace (NYSE:DT) on 1/16/2025 |
DOCN DigitalOcean | $37.82
-1.2% | 1/16/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | $39.00 | N/A | View details for Cantor Fitzgerald rating of DigitalOcean (NYSE:DOCN) on 1/16/2025 |
WDC Western Digital | $68.03
-0.9% | 1/17/2025 | Reiterated by | Cantor Fitzgerald | Analyst C J Muse | Overweight -> Overweight | $95.00 -> $95.00 | Medium | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 1/17/2025 |
UNH UnitedHealth Group | $524.28
+0.9% | 1/17/2025 | Reiterated by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $700.00 -> $700.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 1/17/2025 |
PSNY Polestar Automotive Holding UK | $1.02
-2.4% | 1/17/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Overweight -> Neutral | | Medium | View details for Cantor Fitzgerald rating of Polestar Automotive Holding UK (NASDAQ:PSNY) on 1/17/2025 |
ZM Zoom Video Communications | $77.21
-2.6% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral | $87.00 | High | View details for Cantor Fitzgerald rating of Zoom Video Communications (NASDAQ:ZM) on 1/17/2025 |
SNOW Snowflake | $176.04
-0.8% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Overweight | $201.00 | Low | View details for Cantor Fitzgerald rating of Snowflake (NYSE:SNOW) on 1/17/2025 |
NOW ServiceNow | $1,121.23
-0.4% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Overweight | $1,332.00 | Low | View details for Cantor Fitzgerald rating of ServiceNow (NYSE:NOW) on 1/17/2025 |
PLTR Palantir Technologies | $77.64
+1.0% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral | $72.00 | Medium | View details for Cantor Fitzgerald rating of Palantir Technologies (NASDAQ:PLTR) on 1/17/2025 |
ORCL Oracle | $184.79
+0.3% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Overweight | $214.00 | Low | View details for Cantor Fitzgerald rating of Oracle (NYSE:ORCL) on 1/17/2025 |
NICE NICE | $159.44
-3.4% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral | $176.00 | Medium | View details for Cantor Fitzgerald rating of NICE (NASDAQ:NICE) on 1/17/2025 |
MDB MongoDB | $255.02
-2.2% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Overweight | $344.00 | Low | View details for Cantor Fitzgerald rating of MongoDB (NASDAQ:MDB) on 1/17/2025 |
MNDY monday.com | $245.21
-3.4% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Overweight | $292.00 | Low | View details for Cantor Fitzgerald rating of monday.com (NASDAQ:MNDY) on 1/17/2025 |
MSFT Microsoft | $442.93
-0.7% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Overweight | $509.00 | Medium | View details for Cantor Fitzgerald rating of Microsoft (NASDAQ:MSFT) on 1/17/2025 |
INFA Informatica | $24.61
-1.3% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral | $29.00 | Low | View details for Cantor Fitzgerald rating of Informatica (NYSE:INFA) on 1/17/2025 |
FIVN Five9 | $38.84
-2.2% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Overweight | $46.00 | High | View details for Cantor Fitzgerald rating of Five9 (NASDAQ:FIVN) on 1/17/2025 |
ESTC Elastic | $104.87
+3.6% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral | $108.00 | Medium | View details for Cantor Fitzgerald rating of Elastic (NYSE:ESTC) on 1/17/2025 |
DT Dynatrace | $54.93
+1.0% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral | $58.00 | Low | View details for Cantor Fitzgerald rating of Dynatrace (NYSE:DT) on 1/17/2025 |
DOCN DigitalOcean | $37.82
-1.2% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral | $39.00 | High | View details for Cantor Fitzgerald rating of DigitalOcean (NYSE:DOCN) on 1/17/2025 |
DDOG Datadog | $142.23
+1.5% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of Datadog (NASDAQ:DDOG) on 1/17/2025 |
Now that Trump’s be inaugurated, this day will be key (mark your calendar) (Ad) Mark your calendar for January 29th.
Because on that day, I believe we could see a $2 Trillion shock INTO the market…
Unleashing more explosive moves than ever before. So please watch this video now before the hammer falls and it’s too late. |
CVLT Commvault Systems | $160.53
-1.4% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral | $159.00 | High | View details for Cantor Fitzgerald rating of Commvault Systems (NASDAQ:CVLT) on 1/17/2025 |
NET Cloudflare | $122.76
-0.3% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Fitzgerald | Neutral | $111.00 | Medium | View details for Cantor Fitzgerald rating of Cloudflare (NYSE:NET) on 1/17/2025 |
TEAM Atlassian | $264.02
+1.2% | 1/17/2025 | Initiated by | Cantor Fitzgerald | Analyst Thomas Blakey | Neutral | $264.00 | Medium | View details for Cantor Fitzgerald rating of Atlassian (NASDAQ:TEAM) on 1/17/2025 |
PRE Prenetics Global | $5.75
+0.3% | 1/16/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $9.00 -> $9.00 | High | View details for Cantor Fitzgerald rating of Prenetics Global (NASDAQ:PRE) on 1/16/2025 |
FOLD Amicus Therapeutics | $9.48
-0.7% | 1/15/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $21.00 -> $21.00 | Low | View details for Cantor Fitzgerald rating of Amicus Therapeutics (NASDAQ:FOLD) on 1/15/2025 |
APLD Applied Digital | $9.47
-1.8% | 1/15/2025 | Target Lowered by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $15.00 -> $14.00 | High | View details for Cantor Fitzgerald rating of Applied Digital (NASDAQ:APLD) on 1/15/2025 |
PTCT PTC Therapeutics | $44.44
-1.4% | 1/15/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $80.00 -> $76.00 | High | View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 1/15/2025 |
ITCI Intra-Cellular Therapies | $127.29
+0.1% | 1/14/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Duncan | Hold -> Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Intra-Cellular Therapies (NASDAQ:ITCI) on 1/14/2025 |
ORIC ORIC Pharmaceuticals | $9.77
-1.0% | 1/14/2025 | Reiterated by | Cantor Fitzgerald | Analyst Prakhar Agrawal | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 1/14/2025 |
XGN Exagen | $4.04
-0.1% | 1/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $8.00 -> $8.00 | Low | View details for Cantor Fitzgerald rating of Exagen (NASDAQ:XGN) on 1/13/2025 |
IDYA IDEAYA Biosciences | $22.90
-1.0% | 1/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight -> Overweight | | Low | View details for Cantor Fitzgerald rating of IDEAYA Biosciences (NASDAQ:IDYA) on 1/13/2025 |
ONTO Onto Innovation | $216.51
-3.6% | 1/13/2025 | Initiated by | Cantor Fitzgerald | Analyst M. Prisco | Overweight | $250.00 | High | View details for Cantor Fitzgerald rating of Onto Innovation (NYSE:ONTO) on 1/13/2025 |
NVMI Nova | $250.98
-2.3% | 1/13/2025 | Initiated by | Cantor Fitzgerald | Analyst M. Prisco | Overweight | $275.00 | Low | View details for Cantor Fitzgerald rating of Nova (NASDAQ:NVMI) on 1/13/2025 |
CAMT Camtek | $101.97
-3.9% | 1/13/2025 | Initiated by | Cantor Fitzgerald | Analyst M. Prisco | Neutral | $100.00 | Medium | View details for Cantor Fitzgerald rating of Camtek (NASDAQ:CAMT) on 1/13/2025 |
INCY Incyte | $71.52
-1.2% | 1/10/2025 | Reiterated by | Cantor Fitzgerald | Analyst Eric Schmidt | Neutral -> Neutral | | Medium | View details for Cantor Fitzgerald rating of Incyte (NASDAQ:INCY) on 1/10/2025 |
VYGR Voyager Therapeutics | $5.33
-1.8% | 1/10/2025 | Initiated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | $5.73 | High | View details for Cantor Fitzgerald rating of Voyager Therapeutics (NASDAQ:VYGR) on 1/10/2025 |
TVTX Travere Therapeutics | $19.02
-2.3% | 1/10/2025 | Initiated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | | Low | View details for Cantor Fitzgerald rating of Travere Therapeutics (NASDAQ:TVTX) on 1/10/2025 |
DRUG Bright Minds Biosciences | $32.51
-2.5% | 1/10/2025 | Initiated by | Cantor Fitzgerald | Analyst C. Duncan | Overweight | | High | View details for Cantor Fitzgerald rating of Bright Minds Biosciences (NASDAQ:DRUG) on 1/10/2025 |
VRNS Varonis Systems | $44.40
-1.0% | 1/9/2025 | Initiated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Varonis Systems (NASDAQ:VRNS) on 1/9/2025 |
CHKP Check Point Software Technologies | $194.59
+0.2% | 1/9/2025 | Initiated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral | $200.00 | Low | View details for Cantor Fitzgerald rating of Check Point Software Technologies (NASDAQ:CHKP) on 1/9/2025 |
S SentinelOne | $23.23
+0.1% | 1/9/2025 | Initiated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight | $30.00 | Low | View details for Cantor Fitzgerald rating of SentinelOne (NYSE:S) on 1/9/2025 |
ZVRA Zevra Therapeutics | $8.03
-1.5% | 1/8/2025 | Initiated by | Cantor Fitzgerald | - | Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 1/8/2025 |
SABR Sabre | $3.32
-1.6% | 1/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Neutral | $5.00 -> $4.00 | High | View details for Cantor Fitzgerald rating of Sabre (NASDAQ:SABR) on 1/7/2025 |
HUT Hut 8 | $25.62
-0.9% | 1/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $35.00 -> $35.00 | High | View details for Cantor Fitzgerald rating of Hut 8 (NASDAQ:HUT) on 1/7/2025 |
LCID Lucid Group | $2.66
-0.6% | 1/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Neutral | $3.00 -> $3.00 | High | View details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 1/7/2025 |
AVR Anteris Technologies Global | $5.91
-1.3% | 1/7/2025 | Initiated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight | $9.00 | High | View details for Cantor Fitzgerald rating of Anteris Technologies Global (NASDAQ:AVR) on 1/7/2025 |
CIFR Cipher Mining | $5.42
-1.7% | 1/7/2025 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $11.00 -> $11.00 | High | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 1/7/2025 |
WULF TeraWulf | $6.23
0.0% | 1/6/2025 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $11.00 -> $11.00 | N/A | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 1/6/2025 |
RIVN Rivian Automotive | $12.25
-3.5% | 1/6/2025 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $13.00 | N/A | View details for Cantor Fitzgerald rating of Rivian Automotive (NASDAQ:RIVN) on 1/6/2025 |
ATYR Atyr PHARMA | $3.38
-3.5% | 1/6/2025 | Initiated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | | N/A | View details for Cantor Fitzgerald rating of Atyr PHARMA (NASDAQ:ATYR) on 1/6/2025 |
SUPN Supernus Pharmaceuticals | $38.22
+0.1% | 1/6/2025 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $57.00 | N/A | View details for Cantor Fitzgerald rating of Supernus Pharmaceuticals (NASDAQ:SUPN) on 1/6/2025 |
CLDX Celldex Therapeutics | $23.72
-2.2% | 1/2/2025 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $67.00 -> $67.00 | N/A | View details for Cantor Fitzgerald rating of Celldex Therapeutics (NASDAQ:CLDX) on 1/2/2025 |
ETNB 89bio | $6.93
+2.6% | 1/2/2025 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $29.00 -> $29.00 | N/A | View details for Cantor Fitzgerald rating of 89bio (NASDAQ:ETNB) on 1/2/2025 |
RCEL AVITA Medical | $8.64
+1.9% | 12/24/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $21.00 -> $21.00 | N/A | View details for Cantor Fitzgerald rating of AVITA Medical (NASDAQ:RCEL) on 12/24/2024 |
CGNX Cognex | $40.11
-0.7% | 12/20/2024 | Upgraded by | Cantor Fitzgerald | Analyst T. Jensen | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of Cognex (NASDAQ:CGNX) on 12/20/2024 |
MPAA Motorcar Parts of America | $7.16
-0.3% | 12/20/2024 | Initiated by | Cantor Fitzgerald | Analyst D. Soderberg | Overweight | $14.00 | N/A | View details for Cantor Fitzgerald rating of Motorcar Parts of America (NASDAQ:MPAA) on 12/20/2024 |
APLD Applied Digital | $9.47
-1.8% | 12/20/2024 | Initiated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight | $15.00 | N/A | View details for Cantor Fitzgerald rating of Applied Digital (NASDAQ:APLD) on 12/20/2024 |
CGNX Cognex | $40.11
-0.7% | 12/19/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $49.00 | N/A | View details for Cantor Fitzgerald rating of Cognex (NASDAQ:CGNX) on 12/19/2024 |
MU Micron Technology | $103.72
-5.0% | 12/19/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $150.00 -> $130.00 | N/A | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 12/19/2024 |
PACK Ranpak | $6.25
+0.5% | 12/19/2024 | Initiated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight | $11.50 | N/A | View details for Cantor Fitzgerald rating of Ranpak (NYSE:PACK) on 12/19/2024 |
UBER Uber Technologies | $67.87
+0.1% | 12/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $90.00 -> $90.00 | N/A | View details for Cantor Fitzgerald rating of Uber Technologies (NYSE:UBER) on 12/18/2024 |
AGIO Agios Pharmaceuticals | $33.74
-0.9% | 12/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Agios Pharmaceuticals (NASDAQ:AGIO) on 12/18/2024 |
ALXO ALX Oncology | $1.45
-19.3% | 12/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of ALX Oncology (NASDAQ:ALXO) on 12/18/2024 |
PVLA Palvella Therapeutics | $12.82
-2.5% | 12/18/2024 | Initiated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight | | N/A | View details for Cantor Fitzgerald rating of Palvella Therapeutics (NASDAQ:PVLA) on 12/18/2024 |
ACHR Archer Aviation | $9.60
-1.8% | 12/18/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $13.00 | N/A | View details for Cantor Fitzgerald rating of Archer Aviation (NYSE:ACHR) on 12/18/2024 |
IDYA IDEAYA Biosciences | $22.90
-1.0% | 12/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of IDEAYA Biosciences (NASDAQ:IDYA) on 12/17/2024 |
BHVN Biohaven | $39.25
-3.2% | 12/17/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 12/17/2024 |
TLSI TriSalus Life Sciences | $4.98
+1.5% | 12/17/2024 | Initiated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight | $10.00 | N/A | View details for Cantor Fitzgerald rating of TriSalus Life Sciences (NASDAQ:TLSI) on 12/17/2024 |
ESPR Esperion Therapeutics | $2.12
-3.9% | 12/17/2024 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $8.00 | N/A | View details for Cantor Fitzgerald rating of Esperion Therapeutics (NASDAQ:ESPR) on 12/17/2024 |
AQST Aquestive Therapeutics | $3.11
-1.1% | 12/17/2024 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $17.00 | N/A | View details for Cantor Fitzgerald rating of Aquestive Therapeutics (NASDAQ:AQST) on 12/17/2024 |
Now that Trump’s be inaugurated, this day will be key (mark your calendar) (Ad) Mark your calendar for January 29th.
Because on that day, I believe we could see a $2 Trillion shock INTO the market…
Unleashing more explosive moves than ever before. So please watch this video now before the hammer falls and it’s too late. |
ARCT Arcturus Therapeutics | $16.01
-4.4% | 12/16/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Arcturus Therapeutics (NASDAQ:ARCT) on 12/16/2024 |
AXSM Axsome Therapeutics | $103.04
+0.8% | 12/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $121.00 -> $121.00 | N/A | View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 12/12/2024 |
BMRN BioMarin Pharmaceutical | $61.33
-1.1% | 12/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $90.00 -> $90.00 | N/A | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 12/12/2024 |
GILD Gilead Sciences | $92.45
-0.6% | 12/11/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $80.00 -> $80.00 | N/A | View details for Cantor Fitzgerald rating of Gilead Sciences (NASDAQ:GILD) on 12/11/2024 |
CNC Centene | $63.92
+0.6% | 12/11/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $90.00 -> $90.00 | N/A | View details for Cantor Fitzgerald rating of Centene (NYSE:CNC) on 12/11/2024 |
ZURA Zura Bio | $1.69
-5.9% | 12/11/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Zura Bio (NASDAQ:ZURA) on 12/11/2024 |
TRML Tourmaline Bio | $17.49
-0.9% | 12/11/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $25.00 -> $25.00 | N/A | View details for Cantor Fitzgerald rating of Tourmaline Bio (NASDAQ:TRML) on 12/11/2024 |
JANX Janux Therapeutics | $43.41
+8.0% | 12/11/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $200.00 -> $200.00 | N/A | View details for Cantor Fitzgerald rating of Janux Therapeutics (NASDAQ:JANX) on 12/11/2024 |
BEAM Beam Therapeutics | $25.48
-3.4% | 12/10/2024 | Upgraded by | Cantor Fitzgerald | Analyst R. Bienkowski | Hold | | N/A | View details for Cantor Fitzgerald rating of Beam Therapeutics (NASDAQ:BEAM) on 12/10/2024 |
QURE uniQure | $14.86
-2.8% | 12/10/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $28.00 -> $58.00 | N/A | View details for Cantor Fitzgerald rating of uniQure (NASDAQ:QURE) on 12/10/2024 |
RIGL Rigel Pharmaceuticals | $21.34
-2.2% | 12/10/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $15.00 -> $25.00 | N/A | View details for Cantor Fitzgerald rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 12/10/2024 |
STOK Stoke Therapeutics | $10.16
+1.3% | 12/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Stoke Therapeutics (NASDAQ:STOK) on 12/10/2024 |
TSLA Tesla | $413.52
-0.4% | 12/10/2024 | Target Raised by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Neutral | $255.00 -> $365.00 | N/A | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 12/10/2024 |
ACHC Acadia Healthcare | $43.73
-1.2% | 12/10/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $52.00 -> $52.00 | N/A | View details for Cantor Fitzgerald rating of Acadia Healthcare (NASDAQ:ACHC) on 12/10/2024 |
AUR Aurora Innovation | $7.00
+0.4% | 12/10/2024 | Initiated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight | $10.00 | N/A | View details for Cantor Fitzgerald rating of Aurora Innovation (NASDAQ:AUR) on 12/10/2024 |
HUT Hut 8 | C$37.68
+1.3% | 12/9/2024 | Upgraded by | Cantor Fitzgerald | Analyst B. Knoblauch | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of Hut 8 (TSE:HUT) on 12/9/2024 |
MREO Mereo BioPharma Group | $2.87
-1.8% | 12/8/2024 | Upgraded by | Cantor Fitzgerald | Analyst K. Kluska | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 12/8/2024 |
KALV KalVista Pharmaceuticals | $8.57
+0.1% | 12/9/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of KalVista Pharmaceuticals (NASDAQ:KALV) on 12/9/2024 |
KURA Kura Oncology | $7.96
+1.2% | 12/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Kura Oncology (NASDAQ:KURA) on 12/9/2024 |
LEGN Legend Biotech | $36.53
-2.4% | 12/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $83.00 -> $83.00 | N/A | View details for Cantor Fitzgerald rating of Legend Biotech (NASDAQ:LEGN) on 12/9/2024 |
HUT Hut 8 | $25.62
-0.9% | 12/9/2024 | Initiated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $35.00 -> $35.00 | N/A | View details for Cantor Fitzgerald rating of Hut 8 (NASDAQ:HUT) on 12/9/2024 |
NNOX Nano-X Imaging | $8.47
-5.9% | 12/6/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $11.00 -> $12.00 | N/A | View details for Cantor Fitzgerald rating of Nano-X Imaging (NASDAQ:NNOX) on 12/6/2024 |
GTLB GitLab | $63.12
-0.9% | 12/6/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $75.00 -> $80.00 | N/A | View details for Cantor Fitzgerald rating of GitLab (NASDAQ:GTLB) on 12/6/2024 |
RBRK Rubrik | $71.18
-0.2% | 12/6/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $58.00 -> $70.00 | N/A | View details for Cantor Fitzgerald rating of Rubrik (NYSE:RBRK) on 12/6/2024 |
CXM Sprinklr | $8.71
+0.5% | 12/5/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Neutral -> Neutral | $9.00 -> $9.00 | N/A | View details for Cantor Fitzgerald rating of Sprinklr (NYSE:CXM) on 12/5/2024 |
COUR Coursera | $8.19
-1.1% | 12/5/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $10.00 -> $10.00 | N/A | View details for Cantor Fitzgerald rating of Coursera (NYSE:COUR) on 12/5/2024 |
RZLV Rezolve AI | $3.00
-5.2% | 12/5/2024 | Initiated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight | $5.00 | N/A | View details for Cantor Fitzgerald rating of Rezolve AI (NASDAQ:RZLV) on 12/5/2024 |
TNGX Tango Therapeutics | $3.01
-2.4% | 12/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Tango Therapeutics (NASDAQ:TNGX) on 12/5/2024 |
WULF TeraWulf | $6.23
0.0% | 12/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $11.00 -> $11.00 | N/A | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 12/4/2024 |
PRE Prenetics Global | $5.75
+0.3% | 12/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $9.00 -> $9.00 | N/A | View details for Cantor Fitzgerald rating of Prenetics Global (NASDAQ:PRE) on 12/4/2024 |
MRVL Marvell Technology | $124.24
-0.8% | 12/4/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $120.00 -> $135.00 | N/A | View details for Cantor Fitzgerald rating of Marvell Technology (NASDAQ:MRVL) on 12/4/2024 |
RNAC Cartesian Therapeutics | $18.56
-2.6% | 12/2/2024 | Upgraded by | Cantor Fitzgerald | Analyst K. Kluska | Hold | | N/A | View details for Cantor Fitzgerald rating of Cartesian Therapeutics (NASDAQ:RNAC) on 12/2/2024 |
IREN Iris Energy | $11.83
+1.5% | 11/27/2024 | Target Raised by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $20.00 -> $23.00 | N/A | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 11/27/2024 |
PSTX Poseida Therapeutics | $9.50
| 11/26/2024 | Downgraded by | Cantor Fitzgerald | Analyst J. Kim | Strong-Buy -> Hold | | N/A | View details for Cantor Fitzgerald rating of Poseida Therapeutics (NASDAQ:PSTX) on 11/26/2024 |
NNOX Nano-X Imaging | $8.47
-5.9% | 11/26/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $11.00 | N/A | View details for Cantor Fitzgerald rating of Nano-X Imaging (NASDAQ:NNOX) on 11/26/2024 |
ALEC Alector | $1.74
-2.5% | 11/26/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Alector (NASDAQ:ALEC) on 11/26/2024 |
WDC Western Digital | $68.03
-0.9% | 11/26/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $95.00 -> $95.00 | N/A | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 11/26/2024 |
KRNT Kornit Digital | $30.13
-1.0% | 11/26/2024 | Initiated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight | $39.00 | N/A | View details for Cantor Fitzgerald rating of Kornit Digital (NASDAQ:KRNT) on 11/26/2024 |
KROS Keros Therapeutics | $11.44
+0.4% | 11/22/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | | N/A | View details for Cantor Fitzgerald rating of Keros Therapeutics (NASDAQ:KROS) on 11/22/2024 |
CDXS Codexis | $4.86
-0.3% | 11/22/2024 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $11.00 -> $11.00 | N/A | View details for Cantor Fitzgerald rating of Codexis (NASDAQ:CDXS) on 11/22/2024 |
RBRK Rubrik | $71.18
-0.2% | 11/20/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of Rubrik (NYSE:RBRK) on 11/20/2024 |
CRWD CrowdStrike | $374.56
-0.9% | 11/20/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 11/20/2024 |
CRWD CrowdStrike | $374.56
-0.9% | 11/21/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $350.00 -> $370.00 | N/A | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 11/21/2024 |
WIX Wix.com | $234.83
-0.1% | 11/21/2024 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $200.00 -> $240.00 | N/A | View details for Cantor Fitzgerald rating of Wix.com (NASDAQ:WIX) on 11/21/2024 |
NVDA NVIDIA | $145.00
-1.4% | 11/21/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $175.00 -> $175.00 | N/A | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 11/21/2024 |
KURA Kura Oncology | $7.96
+1.2% | 11/21/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Kura Oncology (NASDAQ:KURA) on 11/21/2024 |
PANW Palo Alto Networks | $185.37
-1.2% | 11/21/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $222.50 -> $222.50 | N/A | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 11/21/2024 |
ACRS Aclaris Therapeutics | $2.51
-3.5% | 11/20/2024 | Upgraded by | Cantor Fitzgerald | Analyst L. Chen | Neutral -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Aclaris Therapeutics (NASDAQ:ACRS) on 11/20/2024 |
MDGL Madrigal Pharmaceuticals | $314.71
-3.1% | 11/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Neutral | | N/A | View details for Cantor Fitzgerald rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 11/20/2024 |
QCOM QUALCOMM | $171.03
+0.5% | 11/20/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $160.00 -> $160.00 | N/A | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 11/20/2024 |
Ignore every stock… (Ad) Stocks have been on a tear in 2024…
And there’s plenty of great opportunities out there.
But one expert says you should forget about EVERY stock for a moment and focus on an even bigger opportunity.
The current GOLD supercycle
You see, stocks are a dime a dozen for the most part… And, fortunately, they go up more than they go down.
But every few decades, precious metals have a systematic supercycle that tends to dwarf the potential of just about anything else.
The last time things aligned like this on gold it surged 536% We put together this handy gold guide for you (no cost) so you know what to look for |
ZS Zscaler | $189.70
-1.7% | 11/18/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Hold | | N/A | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 11/18/2024 |
HIVE HIVE Digital Technologies | $3.15
-0.1% | 11/19/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $9.00 -> $9.00 | N/A | View details for Cantor Fitzgerald rating of HIVE Digital Technologies (NASDAQ:HIVE) on 11/19/2024 |
RCKT Rocket Pharmaceuticals | $10.28
-1.9% | 11/19/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $65.00 -> $65.00 | N/A | View details for Cantor Fitzgerald rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 11/19/2024 |
AFMD Affimed | $1.10
-0.5% | 11/19/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Affimed (NASDAQ:AFMD) on 11/19/2024 |
PCT PureCycle Technologies | $9.75
-1.4% | 11/19/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $14.00 | N/A | View details for Cantor Fitzgerald rating of PureCycle Technologies (NASDAQ:PCT) on 11/19/2024 |
INCY Incyte | $71.52
-1.2% | 11/19/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral | | N/A | View details for Cantor Fitzgerald rating of Incyte (NASDAQ:INCY) on 11/19/2024 |
FTNT Fortinet | $96.10
-2.2% | 11/19/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $88.00 -> $95.00 | N/A | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 11/19/2024 |
SYM Symbotic | $32.80
-1.5% | 11/19/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 -> $60.00 | N/A | View details for Cantor Fitzgerald rating of Symbotic (NASDAQ:SYM) on 11/19/2024 |
SEPN Septerna | $18.85
-2.8% | 11/19/2024 | Initiated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight | $50.00 | N/A | View details for Cantor Fitzgerald rating of Septerna (NASDAQ:SEPN) on 11/19/2024 |
SSTI SoundThinking | $12.94
-0.7% | 11/14/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 11/14/2024 |
CDXS Codexis | $4.86
-0.3% | 11/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $11.00 -> $11.00 | N/A | View details for Cantor Fitzgerald rating of Codexis (NASDAQ:CDXS) on 11/15/2024 |
AMAT Applied Materials | $189.25
-3.2% | 11/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $250.00 -> $250.00 | N/A | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 11/15/2024 |
ASND Ascendis Pharma A/S | $124.06
-1.4% | 11/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $170.00 -> $170.00 | N/A | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 11/15/2024 |
ELUT Elutia | $3.13
-3.8% | 11/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $10.00 | N/A | View details for Cantor Fitzgerald rating of Elutia (NASDAQ:ELUT) on 11/15/2024 |
LUCD Lucid Diagnostics | $0.84
+2.2% | 11/15/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 -> $2.00 | N/A | View details for Cantor Fitzgerald rating of Lucid Diagnostics (NASDAQ:LUCD) on 11/15/2024 |
ANNX Annexon | $4.06
-2.2% | 11/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Annexon (NASDAQ:ANNX) on 11/15/2024 |
SPRO Spero Therapeutics | $0.91
+3.5% | 11/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Spero Therapeutics (NASDAQ:SPRO) on 11/15/2024 |
LUNR Intuitive Machines | $21.82
-2.8% | 11/15/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $15.00 | N/A | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 11/15/2024 |
OMER Omeros | $9.07
-2.4% | 11/14/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral | | N/A | View details for Cantor Fitzgerald rating of Omeros (NASDAQ:OMER) on 11/14/2024 |
CSLR Complete Solaria | $1.89
+0.5% | 11/14/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 -> $6.00 | N/A | View details for Cantor Fitzgerald rating of Complete Solaria (NASDAQ:CSLR) on 11/14/2024 |
RKLB Rocket Lab USA | $29.10
-1.7% | 11/14/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 -> $24.00 | N/A | View details for Cantor Fitzgerald rating of Rocket Lab USA (NASDAQ:RKLB) on 11/14/2024 |
CYBR CyberArk Software | $354.25
-1.2% | 11/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $335.00 -> $335.00 | N/A | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 11/14/2024 |
MRNS Marinus Pharmaceuticals | $0.54
-0.6% | 11/14/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 -> $4.00 | N/A | View details for Cantor Fitzgerald rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 11/14/2024 |
ALMS Alumis | $6.57
-4.9% | 11/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | N/A | View details for Cantor Fitzgerald rating of Alumis (NASDAQ:ALMS) on 11/14/2024 |
CAPR Capricor Therapeutics | $14.41
-3.3% | 11/14/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $25.00 -> $30.00 | N/A | View details for Cantor Fitzgerald rating of Capricor Therapeutics (NASDAQ:CAPR) on 11/14/2024 |
INVZ Innoviz Technologies | $1.80
-5.0% | 11/14/2024 | Downgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Neutral | | N/A | View details for Cantor Fitzgerald rating of Innoviz Technologies (NASDAQ:INVZ) on 11/14/2024 |
GTLB GitLab | $63.12
-0.9% | 11/12/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of GitLab (NASDAQ:GTLB) on 11/12/2024 |
TSHA Taysha Gene Therapies | $1.51
-1.6% | 11/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 -> $7.00 | N/A | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 11/12/2024 |
ALXO ALX Oncology | $1.45
-19.3% | 11/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of ALX Oncology (NASDAQ:ALXO) on 11/12/2024 |
OUST Ouster | $10.71
-0.5% | 11/11/2024 | Upgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Overweight | $12.00 -> $10.00 | N/A | View details for Cantor Fitzgerald rating of Ouster (NYSE:OUST) on 11/11/2024 |
CDE Coeur Mining | $6.23
-2.1% | 11/7/2024 | Upgraded by | Cantor Fitzgerald | Analyst M. Kozak | Hold -> Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of Coeur Mining (NYSE:CDE) on 11/7/2024 |
NRDY Nerdy | $1.61
-0.3% | 11/8/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Neutral | $6.00 -> $1.00 | N/A | View details for Cantor Fitzgerald rating of Nerdy (NYSE:NRDY) on 11/8/2024 |
FOLD Amicus Therapeutics | $9.48
-0.7% | 11/7/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 -> $21.00 | N/A | View details for Cantor Fitzgerald rating of Amicus Therapeutics (NASDAQ:FOLD) on 11/7/2024 |
LYFT Lyft | $13.21
-1.6% | 11/7/2024 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $13.00 -> $16.00 | N/A | View details for Cantor Fitzgerald rating of Lyft (NASDAQ:LYFT) on 11/7/2024 |
MELI MercadoLibre | $1,816.53
-0.1% | 11/7/2024 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $2,530.00 -> $2,300.00 | N/A | View details for Cantor Fitzgerald rating of MercadoLibre (NASDAQ:MELI) on 11/7/2024 |
TRIP Tripadvisor | $16.35
+3.9% | 11/7/2024 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Underweight -> Underweight | $12.00 -> $11.00 | N/A | View details for Cantor Fitzgerald rating of Tripadvisor (NASDAQ:TRIP) on 11/7/2024 |
QCOM QUALCOMM | $171.03
+0.5% | 11/7/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $160.00 -> $160.00 | N/A | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 11/7/2024 |
KVYO Klaviyo | $42.47
-0.4% | 11/7/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $33.00 -> $47.00 | N/A | View details for Cantor Fitzgerald rating of Klaviyo (NYSE:KVYO) on 11/7/2024 |
JANX Janux Therapeutics | $43.41
+8.0% | 11/7/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $100.00 -> $100.00 | N/A | View details for Cantor Fitzgerald rating of Janux Therapeutics (NASDAQ:JANX) on 11/7/2024 |
GILD Gilead Sciences | $92.45
-0.6% | 11/7/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $70.00 -> $80.00 | N/A | View details for Cantor Fitzgerald rating of Gilead Sciences (NASDAQ:GILD) on 11/7/2024 |
SRPT Sarepta Therapeutics | $114.60
-1.3% | 11/7/2024 | Upgraded by | Cantor Fitzgerald | Analyst K. Kluska | Neutral -> Overweight | $152.00 -> $167.00 | N/A | View details for Cantor Fitzgerald rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/7/2024 |
QURE uniQure | $14.86
-2.8% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $28.00 -> $28.00 | N/A | View details for Cantor Fitzgerald rating of uniQure (NASDAQ:QURE) on 11/6/2024 |
PCVX Vaxcyte | $84.63
-2.3% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Vaxcyte (NASDAQ:PCVX) on 11/6/2024 |
BBAI BigBear.ai | $4.19
-5.7% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | $3.50 | N/A | View details for Cantor Fitzgerald rating of BigBear.ai (NYSE:BBAI) on 11/6/2024 |
NVO Novo Nordisk A/S | $80.68
+0.1% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $160.00 -> $160.00 | N/A | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 11/6/2024 |
GFS GlobalFoundries | $41.44
-2.2% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $40.00 -> $40.00 | N/A | View details for Cantor Fitzgerald rating of GlobalFoundries (NASDAQ:GFS) on 11/6/2024 |
KURA Kura Oncology | $7.96
+1.2% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Kura Oncology (NASDAQ:KURA) on 11/6/2024 |
XMTR Xometry | $33.26
+0.8% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Underweight -> Underweight | $12.00 | N/A | View details for Cantor Fitzgerald rating of Xometry (NASDAQ:XMTR) on 11/6/2024 |
RARE Ultragenyx Pharmaceutical | $43.10
+0.4% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $116.00 -> $116.00 | N/A | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 11/6/2024 |
EVEX EVE | $4.73
-3.1% | 11/5/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $5.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of EVE (NYSE:EVEX) on 11/5/2024 |
Ignore every stock… (Ad) Stocks have been on a tear in 2024…
And there’s plenty of great opportunities out there.
But one expert says you should forget about EVERY stock for a moment and focus on an even bigger opportunity.
The current GOLD supercycle
You see, stocks are a dime a dozen for the most part… And, fortunately, they go up more than they go down.
But every few decades, precious metals have a systematic supercycle that tends to dwarf the potential of just about anything else.
The last time things aligned like this on gold it surged 536% We put together this handy gold guide for you (no cost) so you know what to look for |
VRTX Vertex Pharmaceuticals | $425.39
-0.6% | 11/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $480.00 -> $480.00 | Medium | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 11/5/2024 |
ASND Ascendis Pharma A/S | $124.06
-1.4% | 11/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $170.00 -> $170.00 | High | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 11/4/2024 |
NXPI NXP Semiconductors | $215.37
-0.3% | 11/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $270.00 -> $270.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 11/4/2024 |
PRLB Proto Labs | $39.73
-0.3% | 11/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $40.00 -> $40.00 | High | View details for Cantor Fitzgerald rating of Proto Labs (NYSE:PRLB) on 11/4/2024 |
PANW Palo Alto Networks | $185.37
-1.2% | 11/1/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 11/1/2024 |
PANW Palo Alto Networks | $185.37
-1.2% | 10/31/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $200.00 -> $207.50 | Low | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 10/31/2024 |
AMD Advanced Micro Devices | $122.77
-0.8% | 10/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 -> $180.00 | Medium | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 10/30/2024 |
BMRN BioMarin Pharmaceutical | $61.33
-1.1% | 10/30/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $110.00 -> $90.00 | High | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 10/30/2024 |
SNAP Snap | $10.55
+0.8% | 10/30/2024 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $8.00 -> $9.00 | Low | View details for Cantor Fitzgerald rating of Snap (NYSE:SNAP) on 10/30/2024 |
GOOGL Alphabet | $198.59
+0.1% | 10/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $190.00 -> $190.00 | High | View details for Cantor Fitzgerald rating of Alphabet (NASDAQ:GOOGL) on 10/30/2024 |
IREN Iris Energy | $11.83
+1.5% | 10/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $20.00 -> $20.00 | Medium | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 10/30/2024 |
HRMY Harmony Biosciences | $37.10
-4.0% | 10/30/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $51.00 -> $58.00 | High | View details for Cantor Fitzgerald rating of Harmony Biosciences (NASDAQ:HRMY) on 10/30/2024 |
THC Tenet Healthcare | $136.76
+1.7% | 10/30/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $168.00 -> $177.00 | Low | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 10/30/2024 |
ENVX Enovix | $10.97
-4.1% | 10/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 -> $30.00 | High | View details for Cantor Fitzgerald rating of Enovix (NASDAQ:ENVX) on 10/30/2024 |
UDMY Udemy | $7.23
-2.9% | 10/30/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $18.00 -> $11.00 | High | View details for Cantor Fitzgerald rating of Udemy (NASDAQ:UDMY) on 10/30/2024 |
ABEO Abeona Therapeutics | $5.17
+0.6% | 10/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $18.00 -> $18.00 | High | View details for Cantor Fitzgerald rating of Abeona Therapeutics (NASDAQ:ABEO) on 10/29/2024 |
FROG JFrog | $34.04
-0.8% | 10/29/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight | $35.00 | Low | View details for Cantor Fitzgerald rating of JFrog (NASDAQ:FROG) on 10/29/2024 |
FTNT Fortinet | $96.10
-2.2% | 10/29/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $65.00 -> $88.00 | Medium | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 10/29/2024 |
CYBR CyberArk Software | $354.25
-1.2% | 10/29/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $300.00 -> $335.00 | High | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 10/29/2024 |
HIVE HIVE Digital Technologies | $3.15
-0.1% | 10/29/2024 | Initiated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight | $9.00 | Low | View details for Cantor Fitzgerald rating of HIVE Digital Technologies (NASDAQ:HIVE) on 10/29/2024 |
ZLAB Zai Lab | $25.87
-2.9% | 10/25/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Zai Lab (NASDAQ:ZLAB) on 10/25/2024 |
WDC Western Digital | $68.03
-0.9% | 10/25/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $80.00 -> $95.00 | High | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 10/25/2024 |
COUR Coursera | $8.19
-1.1% | 10/25/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $22.00 -> $10.00 | Medium | View details for Cantor Fitzgerald rating of Coursera (NYSE:COUR) on 10/25/2024 |
ALKS Alkermes | $31.00
+2.6% | 10/25/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $48.00 -> $43.00 | Medium | View details for Cantor Fitzgerald rating of Alkermes (NASDAQ:ALKS) on 10/25/2024 |
UHS Universal Health Services | $187.38
+0.2% | 10/25/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Neutral -> Neutral | $219.00 -> $219.00 | Medium | View details for Cantor Fitzgerald rating of Universal Health Services (NYSE:UHS) on 10/25/2024 |
MRNS Marinus Pharmaceuticals | $0.54
-0.6% | 10/25/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $4.00 | High | View details for Cantor Fitzgerald rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 10/25/2024 |
LRCX Lam Research | $80.23
-3.6% | 10/24/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $100.00 -> $100.00 | Medium | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 10/24/2024 |
PI Impinj | $135.25
-2.5% | 10/24/2024 | Target Raised by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $205.00 -> $260.00 | High | View details for Cantor Fitzgerald rating of Impinj (NASDAQ:PI) on 10/24/2024 |
MOH Molina Healthcare | $304.09
+0.5% | 10/24/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $406.00 -> $406.00 | High | View details for Cantor Fitzgerald rating of Molina Healthcare (NYSE:MOH) on 10/24/2024 |
KROS Keros Therapeutics | $11.44
+0.4% | 10/24/2024 | Initiated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | | High | View details for Cantor Fitzgerald rating of Keros Therapeutics (NASDAQ:KROS) on 10/24/2024 |
CI The Cigna Group | $289.83
+0.3% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $400.00 -> $400.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 10/23/2024 |
TXN Texas Instruments | $196.44
-0.3% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $200.00 -> $200.00 | Medium | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 10/23/2024 |
TSLA Tesla | $413.52
-0.4% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Neutral | $245.00 -> $245.00 | Low | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 10/23/2024 |
BHVN Biohaven | $39.25
-3.2% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Medium | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 10/23/2024 |
CVRX CVRx | $17.24
+0.2% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Overweight | $14.00 -> $14.00 | Low | View details for Cantor Fitzgerald rating of CVRx (NASDAQ:CVRX) on 10/23/2024 |
STX Seagate Technology | $107.20
-0.9% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $125.00 -> $125.00 | Medium | View details for Cantor Fitzgerald rating of Seagate Technology (NASDAQ:STX) on 10/23/2024 |
REGN Regeneron Pharmaceuticals | $680.40
+0.1% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $1,015.00 -> $1,015.00 | Low | View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 10/23/2024 |
PFE Pfizer | $26.09
+0.3% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $45.00 -> $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 10/23/2024 |
AMGN Amgen | $273.43
0.0% | 10/22/2024 | Reiterated by | Cantor Fitzgerald | Analyst O. Brayer | Overweight -> Overweight | $405.00 -> $405.00 | High | View details for Cantor Fitzgerald rating of Amgen (NASDAQ:AMGN) on 10/22/2024 |
RARE Ultragenyx Pharmaceutical | $43.10
+0.4% | 10/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $116.00 -> $116.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 10/22/2024 |
BMY Bristol-Myers Squibb | $57.89
+1.4% | 10/18/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $50.00 -> $50.00 | Low | View details for Cantor Fitzgerald rating of Bristol-Myers Squibb (NYSE:BMY) on 10/18/2024 |
VSTM Verastem | $5.52
| 10/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | High | View details for Cantor Fitzgerald rating of Verastem (NASDAQ:VSTM) on 10/18/2024 |
CYTK Cytokinetics | $45.00
-3.9% | 10/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | High | View details for Cantor Fitzgerald rating of Cytokinetics (NASDAQ:CYTK) on 10/18/2024 |
ELV Elevance Health | $398.48
+2.0% | 10/18/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $600.00 -> $485.00 | Medium | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 10/18/2024 |
ZURA Zura Bio | $1.69
-5.9% | 10/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight | | Low | View details for Cantor Fitzgerald rating of Zura Bio (NASDAQ:ZURA) on 10/18/2024 |
PCT PureCycle Technologies | $9.75
-1.4% | 10/18/2024 | Initiated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight | $14.00 | High | View details for Cantor Fitzgerald rating of PureCycle Technologies (NASDAQ:PCT) on 10/18/2024 |
UNH UnitedHealth Group | $524.28
+0.9% | 10/16/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $591.00 -> $644.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 10/16/2024 |
JNJ Johnson & Johnson | $146.75
+1.0% | 10/16/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $215.00 -> $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 10/16/2024 |
META Meta Platforms | $626.06
+0.4% | 10/16/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $670.00 -> $670.00 | Low | View details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 10/16/2024 |
TRML Tourmaline Bio | $17.49
-0.9% | 10/15/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Schimmer | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Tourmaline Bio (NASDAQ:TRML) on 10/15/2024 |
IRON Disc Medicine | $56.12
-4.1% | 10/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $85.00 -> $85.00 | Low | View details for Cantor Fitzgerald rating of Disc Medicine (NASDAQ:IRON) on 10/15/2024 |
IDYA IDEAYA Biosciences | $22.90
-1.0% | 10/15/2024 | Initiated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight | | Medium | View details for Cantor Fitzgerald rating of IDEAYA Biosciences (NASDAQ:IDYA) on 10/15/2024 |
LMAT LeMaitre Vascular | $96.39
-1.6% | 10/15/2024 | Initiated by | Cantor Fitzgerald | Analyst R. Osborn | Neutral | $96.00 | Medium | View details for Cantor Fitzgerald rating of LeMaitre Vascular (NASDAQ:LMAT) on 10/15/2024 |
ZVRA Zevra Therapeutics | $8.03
-1.5% | 10/11/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 10/11/2024 |
MDGL Madrigal Pharmaceuticals | $314.71
-3.1% | 10/11/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Neutral | | Low | View details for Cantor Fitzgerald rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 10/11/2024 |
SYM Symbotic | $32.80
-1.5% | 10/11/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 -> $60.00 | Medium | View details for Cantor Fitzgerald rating of Symbotic (NASDAQ:SYM) on 10/11/2024 |
ALNY Alnylam Pharmaceuticals | $265.49
-0.4% | 10/11/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $220.00 -> $220.00 | Low | View details for Cantor Fitzgerald rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 10/11/2024 |
JNJ Johnson & Johnson | $146.75
+1.0% | 10/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $215.00 -> $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 10/10/2024 |
ALKS Alkermes | $31.00
+2.6% | 10/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $48.00 -> $48.00 | High | View details for Cantor Fitzgerald rating of Alkermes (NASDAQ:ALKS) on 10/10/2024 |
NVO Novo Nordisk A/S | $80.68
+0.1% | 10/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $160.00 -> $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 10/10/2024 |
